IRIS
OLIVIERI, Attilio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.401
EU - Europa 7.131
AS - Asia 3.384
SA - Sud America 508
AF - Africa 231
Continente sconosciuto - Info sul continente non disponibili 55
OC - Oceania 4
Totale 21.714
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.353
UA - Ucraina 1.455
IE - Irlanda 938
IT - Italia 904
RU - Federazione Russa 896
SG - Singapore 884
SE - Svezia 795
HK - Hong Kong 763
TR - Turchia 719
DE - Germania 717
DK - Danimarca 594
CN - Cina 552
BR - Brasile 470
FI - Finlandia 349
KR - Corea 315
GB - Regno Unito 184
FR - Francia 174
CI - Costa d'Avorio 123
MA - Marocco 87
IN - India 64
EU - Europa 54
NL - Olanda 32
CA - Canada 31
BE - Belgio 22
AT - Austria 19
UZ - Uzbekistan 15
JP - Giappone 14
IQ - Iraq 10
MX - Messico 10
AR - Argentina 9
CZ - Repubblica Ceca 8
ES - Italia 8
PL - Polonia 8
RO - Romania 8
EC - Ecuador 7
CO - Colombia 6
VE - Venezuela 6
ZA - Sudafrica 6
BD - Bangladesh 5
GR - Grecia 5
SN - Senegal 5
VN - Vietnam 5
CH - Svizzera 4
IL - Israele 4
IR - Iran 4
JO - Giordania 4
PE - Perù 4
TN - Tunisia 4
AU - Australia 3
BZ - Belize 3
KE - Kenya 3
PK - Pakistan 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
HN - Honduras 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MT - Malta 2
NP - Nepal 2
PH - Filippine 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
HR - Croazia 1
ID - Indonesia 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UY - Uruguay 1
Totale 21.714
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.572
Chandler 1.023
Fairfield 945
Dublin 933
Boardman 847
Hong Kong 761
Ashburn 547
Wilmington 518
Singapore 385
Houston 382
Woodbridge 363
Lawrence 358
Princeton 358
Seattle 346
Des Moines 325
San Mateo 321
Cambridge 257
Ann Arbor 252
New York 252
Moscow 211
The Dalles 162
San Diego 139
Abidjan 123
Centro 104
Milan 86
Beijing 80
Turin 71
Redmond 70
Guangzhou 59
Shanghai 52
Ancona 50
London 48
Los Angeles 41
Rome 39
Helsinki 38
Pune 37
Washington 37
Dallas 33
Venice 31
São Paulo 30
Pianella 27
Porto 27
Wuhan 26
Izmir 24
Marche 24
Norwalk 20
Nuremberg 19
Brussels 18
Prescot 17
Shenzhen 15
Rio de Janeiro 14
Brasília 13
Kilburn 13
Tashkent 13
Wuxi 13
Fayetteville 12
Frankfurt am Main 12
Jinhua 11
Ottawa 11
Yiwu 11
Curitiba 10
Jiaxing 10
Naples 10
Civitanova Marche 9
Falls Church 9
Hanover 9
Praia Grande 9
Belo Horizonte 8
Chiswick 8
Istanbul 8
Palermo 8
Tolentino 8
Wandsworth 8
Florence 7
Hyderabad 7
Montréal 7
New Bedfont 7
Olomouc 7
Southwark 7
Vienna 7
Andria 6
Bari 6
Bologna 6
Goiânia 6
Hangzhou 6
Hounslow 6
Jesi 6
Jinan 6
Pescara 6
Seoul 6
Toronto 6
Andover 5
Baghdad 5
Campinas 5
Catania 5
Chicago 5
Dakar 5
Falconara Marittima 5
Guarulhos 5
Leawood 5
Totale 12.900
Salva come PNG Salva come JPEG
Nome #
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome? 158
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 141
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 130
A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation. 127
A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study. 123
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 116
Glial-like differentiation potential of human mature adipocytes 116
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 113
Predicting failure of hematopoietic stem cell mobilization before it starts: The predicted poor mobilizer (pPM) score 112
A predictive model of varicella-Zoster virus infection after autologous peripheral blood progenitor cell transplantation 111
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 111
Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study 110
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy 107
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 107
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 106
The exosomal surface phenotype and inflamma-miR cargo correlate with MDS diagnosis 103
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 102
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma. 102
Plasticity of human dedifferentiated adipocytes toward endothelial cells 100
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 99
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 99
Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: A survey from the ALWP of the EBMT 98
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 97
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 96
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 96
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease 96
Direct demonstration of cytokeratin filaments by electron microscopy in K562 cell lines in liquid culture 95
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: A GITMO survey on 809 patients autografted in first complete remission 95
Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM) 94
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 94
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: A nationwide retrospective survey from Italy 93
Molecular and functional characterization of human bone marrow adipocytes 92
Application of infrared thermography to determine the correlation between skin temperature and onset of graft versus host disease in patients after bone marrow transplantation: A preliminary study 92
Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80° 90
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 90
Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective study 89
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma 89
PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia. 88
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study 87
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 87
The Time Has Come for Targeted Therapies for AML: Lights and Shadows 87
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 86
Bone marrow adipocytes support haematopoietic stem cell survival 86
'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 86
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib 86
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study 86
Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside. 85
T Repleted Haploidentical Mismatch Allogeneic Versus Autologous Hematopoietic Stem Cell Transplantation In Adult Patients With Acute Leukemia In Complete Remission (CR): A pair-Matched Analysis From The Acute Leukemia Working Party Of EBMT 84
Neurologic Complications IIN 169 Consecutive Allogeneic Stem Cell Transplants: Etiology, Clinical Syndromes and Outcome 84
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. 83
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 83
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 83
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 83
Modern management of anthracycline-induced cardiotoxicity in lymphoma patients: Low occurrence of cardiotoxicity with comprehensive assessment and tailored substitution by nonpegylated liposomal doxorubicin 83
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 83
A policy for the disposal of autologous hematopoietic progenitor cells: report from an Italian consensus panel 82
History and scientific production of clinica medica and clinica ematologica in ancona 82
Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple mieloma 81
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 81
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation. 81
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 81
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 80
Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. 79
Allogeneic Stem Cell Transplantation (Allo-SCT) Following a Reduced-Intensity Conditioning (RIC) Regimen in Relapsed Peripheral T-Cell Lymphomas (PTCL): Results at 4 Year of Median Follow-up 79
[Hodgkin's lymphoma and secondary leukemias]. 79
DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype 79
Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II stud 78
[Autoimmune thrombocytopenic purpura and circulating immune complexes]. 78
DHAP in combination with rituximab vs DHAP alone as salvage treatment for patients with relapsed or refractory diffuse large B-cell lymphoma: a matched-pair analysis. 78
Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells. 77
[Evaluation of the colonization efficiency and in vitro drug sensitivity of the continuous K 562 line]. 77
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 77
In vivo purging with bortezomib and cyclophosphamide, followed by autologous stem cell transplantation and thalidomide consolidation in elderly patients with multiple myeloma 77
Safety and Efficacy of Thiotepa-Based Conditioning Therapy for Allogeneic Transplantation in Acute Myeloid Leukemia - a Survey from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation 77
Nilotinib Treatment of Patients Affected by Chronic Graft-versus-Host Disease Reduces Collagen Production and Skin Fibrosis by Downmodulating the TGF-β and p-SMAD Pathway 76
DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma. 76
Radioimmunotherapy (Y-90-Zevalin (R)) Combined with BEAM Conditioning Regimen and Autologous Stem Cell Transplantation for the Treatment of Non Hodgkin Lymphomas: Results of An Italian Multicenter Study 76
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies 76
Growth factor administration following autologous peripheral blood progenitor cell transplantation. 76
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients. 75
Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders. 75
Response: Imatinib in lung cGVHD of mild to moderate severity 75
Application of growth factors in hematopoietic stem cell transplant [Impiego dei fattori di crescita nel trapianto di cellule staminali emopoietiche] 75
Mobilization policy in multiple myeloma: Minimum target or law of redundancy? Two different approaches by the two sides of the Atlantic Ocean 75
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 75
[Differentiating agents in myelodysplastic syndromes. Analysis of personal cases]. 74
A Prospective Study on the Feasibility of Related and Unrelated Donor Search and Hematopoietic Cell Transplantation for Adults with Acute Leukemia at 31 European Transplant Centers. 74
Lenalidomide and low dose dexamethasone for newly diagnosed primary plasma cell leukemia 74
A multicentre, double-blind, randomised trial comparing ondansetron versus ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis 74
Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma 74
BEEAM (BENDAMUSTINE, ETOPOSIDE, ARA-C, MELPHALAN) PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANT IS SAFE AND EFFECTIVE IN AGGRESSIVE B-CELL NON HODGKIN LYMPHOMA: A PHASE II MULTICENTER STUDY 73
Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: Results of a multicenter study 73
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation 73
Thalidomide plus oral melphalan for advanced multiple myeloma: a phase Ii study 72
Central pontine myelinolysis after hematopoietic stem cell transplantation: survey in 169 consecutive transplanted patients and review of literature 72
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 71
Bone Marrow histopathological and molecular changes of small B-cell lymphomas after rituximab therapy: comparison with clinical response and patients autcome 71
VERY LOW TOXICITY AND GOOD QUALITY OF LIFE IN 48 ELDERLY PATIENTS AUTOTRANSPLANTED FOR HEMATOLOGICAL MALIGNANCIES: A SINGLE CENTER EXPERIENCE 71
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays. 71
Best practice recommendations in: (1) Peripheral blood stem cell mobilization and collection and (2) acute and chronic GvHD treatment using extracorporeal photopheresis. A joint effort from SIdEM (Società Italiana di Emaferesi e Manipolazione Cellulare) and GITMO (Gruppo Italiano Trapianto di Midollo Osseo) 70
Totale 8.839
Salva come PNG Salva come JPEG
Categoria #
all - tutte 138.692
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.692
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020445 0 0 0 0 0 0 0 0 0 0 54 391
2020/20213.868 196 433 522 84 481 267 376 193 445 256 436 179
2021/20222.695 123 692 35 184 18 91 172 220 137 236 206 581
2022/20233.672 442 395 366 231 213 498 9 162 1.019 16 240 81
2023/20242.592 453 64 136 431 439 402 70 58 16 66 59 398
2024/20254.428 644 525 173 61 170 165 753 170 1.205 450 112 0
Totale 22.262